Cite
HARVARD Citation
Ratta, R. et al. (2017). Personalized therapy in renal cell carcinoma: are the different tyrosine kinase inhibitors the same for any patient?. Expert review of precision medicine and drug development. 2 (1), pp. 5-7. [Online].